ABBOTT LABORATORIES — Director's Dealing 2021

Oct 28, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2021-10-27

Reporting Person: Ginascol John F (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-10-27	Common shares without par value	M	45709	$47	Acquired	143262	Direct
2021-10-27	Common shares without par value	F	29588	$128.13	Disposed	113674	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-10-27	Option (right to buy)	$47	M	45709	Disposed	2025-02-19	Common Shares (45709)	Direct

Footnotes

F1: Stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.